ProKidney Analyst Ratings
ProKidney Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/25/2023 | 40.47% | BTIG | → $16 | Initiates Coverage On | → Buy |
| 12/21/2022 | 31.69% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 11/10/2022 | 14.14% | Morgan Stanley | → $13 | Initiates Coverage On | → Equal-Weight |
| 10/18/2022 | 58.03% | UBS | → $18 | Initiates Coverage On | → Buy |
| 10/14/2022 | 40.47% | Citigroup | → $16 | Initiates Coverage On | → Buy |
| 09/02/2022 | — | Evercore ISI Group | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/25/2023 | 40.47% | BTIG | → 16 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 12 月 21 日 | 31.69% | 傑富瑞 | → 15 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 10 月 11 日 | 14.14% | 摩根士丹利 | → 13 美元 | 啓動覆蓋開啓 | → 重量相等 |
| 2022 年 10 月 18 日 | 58.03% | 瑞銀（UBS） | → 18 美元 | 啓動覆蓋開啓 | → 購買 |
| 2022 年 10 月 14 日 | 40.47% | 花旗集團 | → 16 美元 | 啓動覆蓋開啓 | → 購買 |
| 09/02/2022 | — | Evercore ISI 集團 | 啓動覆蓋開啓 | → 跑贏大盤 |
What is the target price for ProKidney (PROK)?
ProKidney (PROK) 的目標價格是多少？
The latest price target for ProKidney (NASDAQ: PROK) was reported by BTIG on July 25, 2023. The analyst firm set a price target for $16.00 expecting PROK to rise to within 12 months (a possible 40.47% upside). 6 analyst firms have reported ratings in the last year.
BTIG於2023年7月25日公佈了ProKidny（納斯達克股票代碼：PROK）的最新目標股價。這家分析公司將目標股價定爲16.00美元，預計PROK將在12個月內升至16.00美元（可能上漲40.47％）。去年有6家分析公司公佈了評級。
What is the most recent analyst rating for ProKidney (PROK)?
分析師對ProKidny (PROK) 的最新評級是多少？
The latest analyst rating for ProKidney (NASDAQ: PROK) was provided by BTIG, and ProKidney initiated their buy rating.
ProKidny（納斯達克股票代碼：PROK）的最新分析師評級由BTIG提供，ProKidny啓動了買入評級。
When is the next analyst rating going to be posted or updated for ProKidney (PROK)?
ProKidny (PROK) 的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProKidney, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProKidney was filed on July 25, 2023 so you should expect the next rating to be made available sometime around July 25, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與ProKidny的高管和客戶交談以及聽取財報電話會議）後得出了股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。ProKidny的最後一次評級是在2023年7月25日提交的，因此您應該預計下一個評級將在2024年7月25日左右公佈。
Is the Analyst Rating ProKidney (PROK) correct?
分析師對 proKidny (PROK) 的評級正確嗎？
While ratings are subjective and will change, the latest ProKidney (PROK) rating was a initiated with a price target of $0.00 to $16.00. The current price ProKidney (PROK) is trading at is $11.39, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的ProKidny（PROK）評級是最初的，目標股價爲0.00美元至16.00美元。ProKidny（PROK）目前的交易價格爲11.39美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。